Iaso Therapeutics
PrivateLast Round
Seed
Jan 25, 2023
Total Funding Raised
$3.17M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Iaso Therapeutics is a biotechnology company that develops next-generation vaccines using a proprietary mutant bacteriophage Qβ (mQβ) platform technology to treat cancer and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Iaso Therapeutics Comparables
Compare Iaso Therapeutics with similar companies based on industry and business-model similarity.
Iaso Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 25, 2023 | ||||
| Grant | Mar 1, 2022 | ||||
| Grant | Jul 15, 2021 | ||||
| Pre Seed | May 31, 2021 | ||||
| Grant | Apr 26, 2021 | ||||
Grant | Sep 18, 2020 |
Iaso Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| National Institute of Allergy and Infectious Diseases | Grant |
| Apjohn Group | Seed |
| Michigan Rise | Seed |
| Michigan State University Student Venture Capital Fund | Grant, Pre Seed |
| Michigan Rise and Red Cedar Ventures | Grant |
| Red Cedar Ventures Pre-Seed Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 25, 2026
Monthly visitors increased 56% MoM.
- Mar 31, 2026
Will present at the 2026 World Vaccine Congress on March 31, 2026.
Iaso Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Iaso Therapeutics's valuation, stock price, and market status.